These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 37243310

  • 1. Echocardiographic score for the screening of cardiac amyloidosis with positive 99m technetium pyrophosphate scintigraphy result.
    Nagai T, Horinouchi H, Hashimoto K, Ichiji T, Yoshioka K, Hashimoto J, Ikari Y.
    Echocardiography; 2023 Jul; 40(7):634-641. PubMed ID: 37243310
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Utility of left atrial and ventricular strain for diagnosis of transthyretin amyloid cardiomyopathy in aortic stenosis.
    Oike F, Usuku H, Yamamoto E, Marume K, Takashio S, Ishii M, Tabata N, Fujisue K, Yamanaga K, Sueta D, Hanatani S, Arima Y, Araki S, Oda S, Kawano H, Soejima H, Matsushita K, Ueda M, Fukui T, Tsujita K.
    ESC Heart Fail; 2022 Jun; 9(3):1976-1986. PubMed ID: 35338611
    [Abstract] [Full Text] [Related]

  • 4. Validation of the Kumamoto criteria for prediction of 99m technetium pyrophosphate scintigraphy positivity as a strategy for diagnosis of transthyretin cardiac amyloidosis: A retrospective cohort study in Kochi.
    Ochi Y, Kubo T, Baba Y, Ueda M, Miyagawa K, Noguchi T, Hirota T, Yamasaki N, Kitaoka H.
    J Cardiol; 2021 Feb; 77(2):124-130. PubMed ID: 33132078
    [Abstract] [Full Text] [Related]

  • 5. Wild type cardiac amyloidosis: is it time to order a nuclear technetium pyrophosphate SPECT imaging study?
    Shen CP, Vanichsarn CT, Pandey AC, Billick K, Rubenson DS, Mohan RC, Heywood JT, Srivastava AV.
    Int J Cardiovasc Imaging; 2023 Jan; 39(1):201-208. PubMed ID: 36598681
    [Abstract] [Full Text] [Related]

  • 6. Usefulness of relative apical longitudinal strain index to predict positive 99m Tc-labeled pyrophosphate scintigraphy findings in advanced-age patients with suspected transthyretin amyloid cardiomyopathy.
    Usuku H, Takashio S, Yamamoto E, Kinoshita Y, Nishi M, Oike F, Marume K, Hirakawa K, Tabata N, Oda S, Misumi Y, Ueda M, Kawano H, Kaikita K, Matsushita K, Ando Y, Matsui H, Tsujita K.
    Echocardiography; 2020 Nov; 37(11):1774-1783. PubMed ID: 33145817
    [Abstract] [Full Text] [Related]

  • 7. Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis.
    Castano A, Haq M, Narotsky DL, Goldsmith J, Weinberg RL, Morgenstern R, Pozniakoff T, Ruberg FL, Miller EJ, Berk JL, Dispenzieri A, Grogan M, Johnson G, Bokhari S, Maurer MS.
    JAMA Cardiol; 2016 Nov 01; 1(8):880-889. PubMed ID: 27557400
    [Abstract] [Full Text] [Related]

  • 8. Comparison of 1-h with 3-h planar 99mTc-pyrophosphate scintigraphy in patients with suspected transthyretin cardiac amyloidosis using SPECT as a reference standard.
    Saitou T, Aikawa T, Manabe O, Nagase A, Kudo T, Oyama-Manabe N.
    Ann Nucl Med; 2023 Feb 01; 37(2):99-107. PubMed ID: 36352186
    [Abstract] [Full Text] [Related]

  • 9. [Noninvasive diagnosis of cardiac involvement by technetium-99m-pyrophosphate (Tc-99m PYP) myocardial scintigraphy in 2 cases of familial amyloid polyneuropathy and 1 case of secondary amyloidosis].
    Takezaki M, Ishida Y, Morozumi T, Tani A, Sato H, Hori M, Kitabatake A, Kamada T, Kimura K, Kozuka T.
    Kaku Igaku; 1989 Dec 01; 26(12):1537-43. PubMed ID: 2560088
    [Abstract] [Full Text] [Related]

  • 10. A case of disappearing amyloid on technetium pyrophosphate scan.
    Wang A, Mahmood U, Tang X, Jain D, Pan S.
    J Nucl Cardiol; 2023 Oct 01; 30(5):1986-1991. PubMed ID: 37340232
    [Abstract] [Full Text] [Related]

  • 11. Combination of Commonly Examined Parameters Is a Useful Predictor of Positive 99 mTc-Labeled Pyrophosphate Scintigraphy Findings in Elderly Patients With Suspected Transthyretin Cardiac Amyloidosis.
    Marume K, Takashio S, Nishi M, Hirakawa K, Yamamoto M, Hanatani S, Oda S, Utsunomiya D, Shiraishi S, Ueda M, Yamashita T, Sakamoto K, Yamamoto E, Kaikita K, Izumiya Y, Yamashita Y, Ando Y, Tsujita K.
    Circ J; 2019 Jul 25; 83(8):1698-1708. PubMed ID: 31189791
    [Abstract] [Full Text] [Related]

  • 12. Serial scanning with technetium pyrophosphate (99mTc-PYP) in advanced ATTR cardiac amyloidosis.
    Castaño A, DeLuca A, Weinberg R, Pozniakoff T, Blaner WS, Pirmohamed A, Bettencourt B, Gollob J, Karsten V, Vest JA, Chiuzan C, Maurer MS, Bokhari S.
    J Nucl Cardiol; 2016 Dec 25; 23(6):1355-1363. PubMed ID: 26453570
    [Abstract] [Full Text] [Related]

  • 13. [Cardiac involvement in systemic amyloidosis: myocardial scintigraphic evaluation].
    Hongo M, Yamada H, Okubo S, Hirayama J, Fujii T, Kusama S, Ikeda S.
    J Cardiogr; 1985 Mar 25; 15(1):163-80. PubMed ID: 2999267
    [Abstract] [Full Text] [Related]

  • 14. A Simple Score to Identify Increased Risk of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection Fraction.
    Davies DR, Redfield MM, Scott CG, Minamisawa M, Grogan M, Dispenzieri A, Chareonthaitawee P, Shah AM, Shah SJ, Wehbe RM, Solomon SD, Reddy YNV, Borlaug BA, AbouEzzeddine OF.
    JAMA Cardiol; 2022 Oct 01; 7(10):1036-1044. PubMed ID: 36069809
    [Abstract] [Full Text] [Related]

  • 15. Global and Regional Variations in Transthyretin Cardiac Amyloidosis: A Comparison of Longitudinal Strain and 99mTc-Pyrophosphate Imaging.
    Lee C, Chao CJ, Agasthi P, Seri AR, Shere A, Mi L, Brown L, Marostica C, Barry T, Yang M, Rosenthal J, Unzek S, Mookadam F, Arsanjani R.
    J Nucl Med Technol; 2022 Mar 01; 50(1):30-37. PubMed ID: 34933921
    [Abstract] [Full Text] [Related]

  • 16. Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement.
    Castaño A, Narotsky DL, Hamid N, Khalique OK, Morgenstern R, DeLuca A, Rubin J, Chiuzan C, Nazif T, Vahl T, George I, Kodali S, Leon MB, Hahn R, Bokhari S, Maurer MS.
    Eur Heart J; 2017 Oct 07; 38(38):2879-2887. PubMed ID: 29019612
    [Abstract] [Full Text] [Related]

  • 17. Light Chain Testing Abnormalities Among Patients With Transthyretin Amyloid Cardiomyopathy Referred for Technetium-99m Pyrophosphate Imaging.
    Alreshq R, Cozzolino M, Lilleness B, Pipilas A, Mendelson L, Joshi T, Muralidhar V, Guardino E, Berk JL, Siddiqi OK, Gopal DM, Sanchorawala V, Ruberg FL.
    Am J Cardiol; 2022 Oct 15; 181():105-112. PubMed ID: 36028388
    [Abstract] [Full Text] [Related]

  • 18. Towards a Diagnosis of Cardiac Amyloidosis: Single Center Experience with 99m Technetium Pyrophosphate Planar Imaging and Opportunities for Standardization of Diagnostic Workflow.
    Saleem M, Sadat B, Van Harn M, Ananthasubramaniam K.
    Medicina (Kaunas); 2023 Feb 16; 59(2):. PubMed ID: 36837580
    [Abstract] [Full Text] [Related]

  • 19. Technetium-99m-pyrophosphate imaging-based computed tomography-guided core-needle biopsy of internal oblique muscle in wild-type transthyretin cardiac amyloidosis.
    Takahashi K, Hiratsuka Y, Iwamura T, Sasaki D, Yamamura N, Kitazawa S, Ueda M, Morioka H, Okura T, Enomoto D, Uemura S, Kono T, Sakaue T, Ikeda S.
    Amyloid; 2024 Mar 16; 31(1):12-21. PubMed ID: 37486102
    [Abstract] [Full Text] [Related]

  • 20. 99m Technetium-pyrophosphate scintigraphy: a practical guide for early diagnosis of transthyretin amyloid cardiomyopathy.
    Tahara N, Lairez O, Endo J, Okada A, Ueda M, Ishii T, Kitano Y, Lee HE, Russo E, Kubo T.
    ESC Heart Fail; 2022 Feb 16; 9(1):251-262. PubMed ID: 34841715
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.